Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer

BACKGROUND: To explore the maximum tolerated dose (MTD) and evaluate the safety of dose escalation using hypofractionated simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) concurrent with chemotherapy for unresectable stage III non-small cell lung cancer (NSCLC). METHODS: Fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qin, Cai, Xu-Wei, Feng, Wen, Yu, Wen, Fu, Xiao-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783483/
https://www.ncbi.nlm.nih.gov/pubmed/35065627
http://dx.doi.org/10.1186/s12885-021-09099-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783483/
https://www.ncbi.nlm.nih.gov/pubmed/35065627
http://dx.doi.org/10.1186/s12885-021-09099-3

Ejemplares similares